Delivery Order SPE2DB20D1100-SPE2DB24FA1T6

Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $3,350.43 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment...
The Defense Logistics Agency (DLA) awarded a $1,741.68 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities...
The U.S. Defense Logistics Agency (DLA) awarded a $6,143.62 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 3 mg/0.5 ml Trulicity pen injectors. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $2,322.24 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, to provide Trulicity 3 mg/0.5 ml pens. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,145.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This delivery order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds as the prime contractor, providing a comprehensive range of pharmaceuticals and...
The Defense Logistics Agency (DLA) awarded a $1,741.68 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565228881 Trulicity 3 mg/0.5 ml pens. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The $2,437.92 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 3 mg/0.5 ml pens. The $15,840.79 contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp serves as the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC allows...
The U.S. Defense Logistics Agency (DLA) awarded a $26,297.53 Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Trulicity 3 mg/0.5 mL pens. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,579.29 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Trulicity 4.5 mg/0.5 ml pens. This contract is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA1T6
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a $2,899.68 firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit organization and subsidiary of AmerisourceBergen Corporation, to provide Trulicity 3 mg/0.5 ml injectable medication pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract has a completion date of February 12, 2024 and does not utilize any set-aside designation.

Generated 5/10/24, 11:15 AM